CG Oncology, Inc.
Irvine, California
Trademarks
TRUVESIC
No. 833529 · Classes 5, 42
ONCOLYTIC IMMUNOTHERAPY
No. 824452 · Classes 5, 42
ONCOLYTIC IMMUNOTHERAPY
No. 826160 · Classes 5, 42
Holder of 3 trademarks, 3 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property. The register names a holder by name and address only, so a mark is listed here when its holder’s name is this entity’s.
Patents
CG0070 ZUR BEHANDLUNG VON BCG RESISTENTEM IN SITU BLASENCARCINOM
EP3610026
VERFAHREN ZUR BEHANDLUNG VON SOLIDEN TUMOREN DURCH KOMBINATIONSTHERAPIE
EP3426271
VERFAHREN ZUR BEHANDLUNG VON SOLIDEN ODER LYMPHATISCHEN TUMOREN DURCH KOMBINATIONSTHERAPIE
EP3365062
Holder of 3 patents, 2 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.